Tag Archives: biopharmaceutical

NUZYRA Continues to be the Primary Driver for Paratek Pharmaceuticals’ Growth

The FDA approved Paratek’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with Community-Acquired Bacterial Pneumonia (CABP)

PRECISIONxtract Increasing Life Sciences Commercialization Capabilities

PRECISIONxtract bolsters its position as an industry leader in providing data-driven insights and technology-enabled solutions addressing the commercialization challenges faced by life science companies

Centene Strengthens Specialty Pharmacy Rare Disease Position with PantherRx Acquisition

Biophama companies are increasingly interested in establishing relationships with  experienced specialty pharmacies to dispense rare disease drugs to patients

Rare Diseases and Orphan Drugs Growth Favorable to Specialty Pharmacies

Biophama companies are increasingly interested in establishing relationships with  experienced specialty pharmacies to dispense rare disease drugs to patients

Optime Care Takes Patient-First Approach for Orphan and Rare Disorders

Optime Care offers a patient-first suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders

Increasing Demand for Drug Based Outcomes

Specialty Pharma Services

Increasing Demand for Drug Based Outcomes – Outcome-based contracts are a relatively new and growing contracting methodology focused on shifting reimbursement from volume to value. The contracts are between a health plan and manufacturer where reimbursement is dependent on pre-defined outcome metrics focused on improving patient responses/health. Currently, the relationship between the pharmaceutical manufacturer, the […]